Aug 7, 2024, 10:50
Lorenza Rimassa: Outcomes in patients with unresectable HCC treated with STRIDE
Lorenza Rimassa, Associate Professor of Medical Oncology at HUNIMED, shared on X:
“Glad to discuss for VJ Oncology the poster on outcomes according to comorbities in patients with unresectable HCC treated with STRIDE in the HIMALAYA trial that I presented at ESMOGI24.
Published by VJ Oncology.”
Source: Lorenza Rimassa/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 22:09
Nov 22, 2024, 21:56
Nov 22, 2024, 21:35
Nov 22, 2024, 21:11
Nov 22, 2024, 21:07
Nov 22, 2024, 20:44